| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,960 |
1,716 |
$671K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,385 |
3,566 |
$343K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,022 |
3,612 |
$324K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,496 |
3,186 |
$211K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,299 |
3,623 |
$186K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,078 |
926 |
$87K |
| 87486 |
|
1,918 |
1,711 |
$80K |
| 87581 |
|
1,914 |
1,709 |
$80K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,343 |
1,154 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
991 |
786 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
999 |
876 |
$44K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,131 |
1,736 |
$33K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
668 |
527 |
$23K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
716 |
636 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,918 |
1,170 |
$20K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
118 |
109 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
115 |
104 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,577 |
1,078 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
146 |
86 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
77 |
71 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
620 |
436 |
$660.67 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
35 |
35 |
$444.09 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$392.00 |
| 81001 |
|
130 |
113 |
$371.80 |
| 99000 |
|
19 |
13 |
$281.52 |
| 36415 |
Collection of venous blood by venipuncture |
17 |
14 |
$69.70 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12 |
12 |
$7.32 |